IRIS
ASCARI, EDOARDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.143
AS - Asia 3.183
EU - Europa 2.813
SA - Sud America 340
AF - Africa 43
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 7
Totale 10.541
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.069
CN - Cina 1.932
IE - Irlanda 686
SG - Singapore 653
UA - Ucraina 468
FI - Finlandia 365
DE - Germania 339
HK - Hong Kong 308
RU - Federazione Russa 284
BR - Brasile 282
SE - Svezia 272
GB - Regno Unito 139
IT - Italia 109
VN - Vietnam 102
FR - Francia 52
IN - India 51
CA - Canada 50
AR - Argentina 25
BD - Bangladesh 19
NL - Olanda 19
ZA - Sudafrica 19
BE - Belgio 17
IR - Iran 17
JP - Giappone 17
PL - Polonia 15
MX - Messico 14
ES - Italia 13
AU - Australia 11
ID - Indonesia 10
EC - Ecuador 9
IQ - Iraq 9
PK - Pakistan 8
SA - Arabia Saudita 8
UZ - Uzbekistan 8
VE - Venezuela 8
AT - Austria 7
DK - Danimarca 6
CO - Colombia 5
MA - Marocco 5
NP - Nepal 5
PY - Paraguay 5
AE - Emirati Arabi Uniti 4
CZ - Repubblica Ceca 4
DZ - Algeria 4
EG - Egitto 4
EU - Europa 4
IL - Israele 4
JO - Giordania 4
RO - Romania 4
TR - Turchia 4
CL - Cile 3
GE - Georgia 3
GR - Grecia 3
KE - Kenya 3
LT - Lituania 3
AZ - Azerbaigian 2
BB - Barbados 2
BH - Bahrain 2
BY - Bielorussia 2
CR - Costa Rica 2
JM - Giamaica 2
KR - Corea 2
KZ - Kazakistan 2
LB - Libano 2
LK - Sri Lanka 2
ML - Mali 2
MU - Mauritius 2
TN - Tunisia 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BO - Bolivia 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CY - Cipro 1
GT - Guatemala 1
HN - Honduras 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MD - Moldavia 1
MY - Malesia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
UY - Uruguay 1
Totale 10.541
Salva come PNG Salva come JPEG
Città #
Dublin 684
Chandler 591
Jacksonville 570
Nanjing 455
Hong Kong 303
Ashburn 299
Singapore 298
Beijing 287
Dallas 285
San Jose 264
Boardman 202
Nanchang 191
Princeton 137
Shenyang 126
Hebei 125
Lawrence 125
Medford 121
Changsha 114
Wilmington 112
Jiaxing 99
Los Angeles 99
Helsinki 91
Ann Arbor 77
Tianjin 74
Hangzhou 72
Munich 70
Moscow 57
New York 56
Buffalo 48
Shanghai 44
Milan 43
Redondo Beach 43
Turku 37
Ho Chi Minh City 35
Woodbridge 33
Norwalk 28
São Paulo 25
Hanoi 24
Verona 24
Montreal 20
Seattle 20
Fairfield 19
Toronto 19
Chicago 18
Brussels 17
Tokyo 16
Guangzhou 15
Houston 15
Warsaw 14
Denver 13
Johannesburg 13
Kunming 13
Santa Clara 12
Brooklyn 11
Jinan 11
Orem 11
San Francisco 11
Zhengzhou 11
The Dalles 10
Auburn Hills 9
Boston 9
Brasília 9
Chennai 9
Des Moines 9
Falkenstein 9
London 9
Phoenix 9
Poplar 9
Ningbo 8
Piscataway 8
San Genesio Ed Uniti 8
Taizhou 8
Atlanta 7
Belo Horizonte 7
Changchun 6
Columbus 6
Falls Church 6
Haiphong 6
Manchester 6
Orange 6
Rio de Janeiro 6
Tashkent 6
Andover 5
Ardabil 5
Fuzhou 5
Lanzhou 5
Melbourne 5
Mexico City 5
Quito 5
Rome 5
Amman 4
Amsterdam 4
Campinas 4
Jeddah 4
Shijiazhuang 4
Sorocaba 4
Stockholm 4
Baghdad 3
Barueri 3
Biên Hòa 3
Totale 6.909
Salva come PNG Salva come JPEG
Nome #
5' Nucleotidase in chronic B cell leukemias: a cytochemical and ultrastructural study 138
A combination regimen of idarubicin and cytosine arabinoside for patients with high-risk myelodysplastic syndromes 133
A modified high-dose dexamethasone regimen for primary systemic amyloidosis 127
A modified high-dose dexamethasone regimen for primary systemic (AL) amyloidosis. 125
[Pathogenetic mechanisms of chronic myeloid leukemia and the antiproliferative effects of alpha and gamma interferons] 120
Acute promyelocitic leukemia toluidine blue subtype. 119
[Biochemical modifications of the erythrocyte membrane in various red cell disorders] 119
Anomalous erythrocytes produced by rabbits with liver damage. 118
Interaction of the anthracycline 4'-iodo-4'-deoxydoxorubicin with amyloid fibrils:inhibition of amyloidogenesis. 117
Characterization of immunoglobulin variable regions of two human pathogenic monoclonal cryocrystalglobulins 116
Ageing of rabbit red cells in vitro: membrane modifications and their possible role in red cell survival in vivo. 114
Acute phase proteins and prognosis in multiple myeloma. 111
AMYLOIDOSIS AL 110
Cytokinetic changes in the peripheral blood of leukemic patients during cytostatic therapy. VI. Effect of arabinosylcytosine. 110
A further case of myeloproliferative syndrome with reciprocal translocation (8;13)(p11;q12) 110
Response to first-line chemotherapy and long-term survival in patients with multiple myeloma: results of the MM87 prospective randomised protocol 108
A prospective, controlled, non-randomized study on prophylactic parenteral dichloromethylene bisphosphonate (clodronate) in multiple myeloma. 108
Severe platelet disfunction in a patient with autoantibodies against membrane glycoproteins IIb-IIIa 108
- Hematological values from quantitative buffy coat analysis (QBC II) system: evaluation in an hematological/oncological outpatient section 107
An atypical myeloproliferative disorder with high thrombotic risk and slow disease progression. 104
The myelodysplastic syndromes: predictive value of eight prognostic systems in 143 cases from a single institution. 104
Advanced breast cancer: a randomized study of different doses of epirubicin associated with fixed doses of cyclophosphamide and 5-fluorouracil. 101
Acquired immune thrombastenia: a new bleeding disorder. 100
Silymarine during maintenance therapy of acute promyelocytic leukemia. 100
[Glycoproteins of the erythrocyte membrane in normal and pathological conditions] 100
A plea to overcome th concept of "staging" and related inadequacy in multiple myeloma. 99
Long-term effects of parenteral dichloromethylene bisphosphonate (CL2MBP) on bone disease of myeloma patients treated with chemotherapy. 99
Reactive hemophagocytosis in Ki-1 positive largeb cell lymphoma: a case study. 98
Anemie megaloblastiche. 98
Acquired cyclic thrombocytopenia-thrombocytosis with periodic defect of platelet function. 98
Analysis of Vlambda-Jlambda expression in plasma cells from primary (AL) amyloidosis and normal bone marrow identifies 3r (lambda III) as a new amyloid-associated germline gene segment 98
Response to cyclosporin A and rhG-CSF in a case of aplastic anemia. 97
On the usefulness of PAS reaction for the prognosis of acute lymphoblastic leukemia. 97
Possible evolution of human parvovirus B19 infection into erythroleukemia 96
The clinical value of tumor burden at diagnosis in Hodgkin lymphoma 96
Effetti sistemici della terapia trombolitica.[Systemic effects of thrombolytic therapy]. 96
[Prophylaxis and therapy of neuro-meningeal involvement of acute lymphoblastic leukemia. Case reports and critical review of literature (author's transl)] 96
[Pure acute monocytic leukaemia: morphological, cytochemical and clinical study of 14 cases (author's transl)]. 95
IMMUNOENZYMATIC DETECTION OF PROTEINS TRANSFERRED ON NITROCELLULOSE AFTER FIXATION AND STAINING IN POLYACRYLAMIDE GEL 93
Survivin expression, apoptosis and proliferation in chronic myelomonocytic leukemia 89
Presentation features of monoclonal gammopathies: analysis of 684 newly diagnosed cases. 88
Biologia e clinica del mieloma multiplo. 88
High versus standard dose methylprednisolone in the acute phase of idiopathic thrombotic thrombocytopenic purpura: a randomized study. 88
A prospective, controlled, nonrandomized study on prophylactic parenteral dichloromethylene bisphosphonate (clodronate) in multiple-myeloma. 88
The effect of red blood cells on platelet aggregation; a study with the whole blood aggregometer 87
Structural features of two monoclonal cryocrystalglobulins causing a rheumatic syndrome with vasculitis 86
CHARACTERIZATION OF ANTI-STREPTOLYSIN O ACTIVITY OF A HUMAN MONOCLONAL IgG LAMDA. 86
STUDY OF THREE PATIENTS WITH MONOCLONAL GAMMAPATHIES AND "LUPUS-LIKE" ANTICOAGULANTS. 85
Changing clinical presentation of multiple myeloma. 85
Membrane CD22 defines circulating myeloma-related cells as mature or later B cells 85
Clinical relevance of two in vitro tests based on CFU-GM assay in the study of granulopoietic failure 85
Sequential administration of interleukin-3 and granulocyte-macrophage colony-stimulating factor following intensified, accelerated CEE (cyclophosphamide, epirubicin, etoposide) chemotherapy: cytokinetic effects on bone marrow hematopoietic progenitors. 84
Significance of marrow-blood barrier for CFU-GM in patients with acute nonlymphoid leukemia (AnLL) 84
Intravenous prostacyclin (as epoprostenol) infusion in thrombotic thrombocytopenic purpura. Four case reports and review of the literature. Italian Cooperative Group for Thrombotic Thrombocytopenic Purpura 84
RELEVANCE OF CLASS, MOLECULAR WEIGHT AND ISOELECTRIC POINT IN PREDICTING HUMAN LIGHT CHAIN AMYLOIDOGENICITY. 83
Cancer chemotherapy-related thrombotic thrombocytopeic purpura: biological evidence of increased nitric oxide production. 83
Sequential vincristine, arabinosylcytosine and daunomycin in acute leukemia: a preliminary report. 83
Effect of anagrelide on platelet count and function in patients with thrombocytosis and myeloproliferative disorders. 83
Treatment of thrombotic thrombocytopenic purpura with high-dose immunoglobulins. Results in 17 patients. Italian Cooperative Group for TTP 83
Effects of desferrrioxamine on normal and leukemic human hematopoietic cell growth: in vitro and in vivo studies 82
Fisiopatologia dell'eritrocito. 82
CYCLIC THROMBOCYTOPENIA-THROMBOCYTOSIS WITH A PERIODIC DEFECT OF PLATELET-FUNCTION - REPORT OF A CASE 82
International prognostic scoring system and other prognostic systems for myelodysplastic syndromes. 81
Glycopeptides of erythrocyte membranes in some hematological disorders 81
Acute non-lymphoblastic leukemia. Correlation between clinical and hematological parameters in 87 adult patients. 81
Serum N-terminal pro-brain natriuretic peptide is a sensitive marker of myocardial dysfunction in AL amyloidosis 81
[Chronic granulomatous disease with sea-blue histiocytosis: a case report (author's transl)]. 81
Left ventricular function in colon cancer patients receiving adjuvant fluoro-folate chemotherapy. An echocardiographic study. 80
Morphological features and prognostic implication in a retrospective analysis of 370 patients with myelodysplastic syndrome 80
Clinical and biological effects of treatment with amifostine in myelodysplastic syndromes 80
Applicazioni cliniche dei fattori di crescita emopoietici. 79
Osteonecrosi avascolare del massiccio facciale in corso di terapia con bisfosfonati [Avascular jaw osteonecrosis associated with bisphophonate therapy]. 79
Expression of p53, bcl-2 and ras oncoproteins in acute leukemias and myelodysplastic syndromes 78
The syndrome of abnormal chromatin clumping in leucocytes: clinical and biological study of a case. 77
Cell cycle status and apoptosis of hematopoietic progenitor cells released into the peripheral blood after taxanes anf granulocyte colony-stimulating factor in breast cancer patients 76
Evidence of a hypercoagulable state in patients with acute lymphoblastic leukemia treated with low dose of E. coli L-asparaginase: a GIMEMA study. 75
Chemotherapy-induced leukonychia 75
Vincristine sulfate for the treatment of thrombotic thrombocytopenic purpura refractory to plasma-exchange. The Italian Cooperative Group for TTP 75
Acute promyelocytic leukemia: morphological and clinical features. 74
Idarubicin and cytosine arabinoside in the induction and maintenance therapy of high risk myelodysplastic syndromes 74
Behaviour of young and old desialylated rabbit erythrocytes in vivo. 73
Applicazioni cliniche della citometria. 73
Lymphocyte reactivity in chronic lymphocytic leukaemia: effect of repeated and prolonged stimulation with PHA and PWM. 73
Cell kinetics in human malignancies studied with in vivo administration of bromodeoxyuridine and flow cytometry 72
Structural modifications in membrane glycoproteins during the erythrocyte life-span. 72
In vivo behaviour of neuraminidase-treated rabbit erythrocytes and reticulocytes 72
Tetrahydrofolate dehydrogenase cytochemistry in acute lymphoblastic leukemia. 72
IL MIELOMA MULTIPLO 72
Experience with poorly myelosuppressive chemotherapy schedules for advanced myeloma. 72
Flow cytometric analysis of multidrug resistance antigen (p glicoprotein) and DNA ploidy in human colon cancer 71
Antiplatelet agents in thrombotic thrombocytopenic purpura (TTP). Results of a randomized multicenter trial by the Italian Cooperative Group for TTP 71
Establishment and characterization of a B-cell line derived from a patient with a myelodysplastic syndrome which expresses myelomonocytic and lymphoid markers. 70
Terapia del mieloma multiplo. 70
Bone marrow morphology and proliferative activity in acquired immunodeficiency syndrome. 70
Flow cytometric analysis of paraffin embedded material in human gastric cancer. 69
Bone marrow myeloid cell kinetics during treatment of small cell carcinoma of the lung with chemotherapy not associated and associated with granulocyte-macrophage colony stimulating factor. 68
Erythrocyte membrane modifications in chronic granulocytic leukaemia 68
Membrane sialic acid and behaviour in vivo of rabbit "stress" macroreticulocytes. 68
Loss of the Y chromosome in smoldering acute leukemia. 68
Thalidomide treatment reduces apoptosis levels in bone marrow cells from patients with myelodysplastic syndromes 67
Totale 8.954
Salva come PNG Salva come JPEG
Categoria #
all - tutte 44.392
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.392
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021460 0 0 0 0 0 0 3 134 32 137 117 37
2021/2022650 9 1 21 10 24 35 12 35 23 32 88 360
2022/20231.811 217 129 21 136 183 174 0 85 777 9 54 26
2023/2024550 80 92 25 59 51 133 15 32 7 14 25 17
2024/20251.566 44 142 37 52 25 49 53 109 391 47 183 434
2025/20262.448 275 254 441 523 421 220 314 0 0 0 0 0
Totale 10.615